Sanofi Upgrades Outlook After Earnings Beat
Wall Street Journal
Sanofi raised its 2023 EPS guidance after it reported second-quarter adjusted earnings that beat analysts’ expectations and despite sales falling short of estimates.
Wall Street Journal
Sanofi raised its 2023 EPS guidance after it reported second-quarter adjusted earnings that beat analysts’ expectations and despite sales falling short of estimates.